Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth quarter and year ended December 31, 2025.

Q4 2025 Earnings Call February 26, 2026 8:30 AM ESTCompany ParticipantsLuis Sanay - Vice President of Investor RelationsJohn Jacobs ...

Pfizer agreement announced in January 2026 for non-exclusive license to utilize Matrix-M® in two infectious disease areas Multiple Material Transfer Agreements signed ...

Paramount Chief David Ellison, who began his pursuit of Warner Bros. last fall, said he was pleased Warner's board ...

From twin Michael B. Jordan's to endless cotton fields, VFX supervisor Michael Ralla and VFX producer James Alexander break ...

It’s almost March, so let’s look at where the Heels currently stand.

Karnataka workers face rising living costs as wage revisions stall amidst soaring inflation and government inaction, ...

The Prince and Princess of Wales visited Wales on Thursday, February 26, as part of their annual visit to mark St David's Day ...

Designing and deploying DSPs FPGAs aren’t the only programmable hardware option, or the only option challenged by AI. While AI makes it easier to design DSPs, there are rising complexities due to the ...

BY SEAN WILLIAMS, PhDSanta FeActually, I won’t use the term AI. It’s too broad: it can mean anything from zero-player tic-tac ...

Management provided a 2026 adjusted total revenue target of $230 million to $270 million, including $35 million to $45 million of Nuvaxovid product sales under existing orders, $40 million to $50 ...

Analyzing FC Porto’s attacking zones over the past month, there is a clear difference since the Zaidu–Pietuszewski duo became ...